Sun Pharmaceutical Industries has decided to proceed with a binding offer of $12 billion for Organon & Co, taking the company to the final stages of its most ambitious overseas acquisition bid as it looks to become a branded and innovative drug-making powerhouse, said people in the know.
PVH +11% on Q4 blowout (EPS $3.82 vs $3.31); nCino +19% on record ACV bookings, 76% EPS beat; Conagra returned to organic growth but missed adj. EPS on 7% COGS inflation. Market: Iran whipsaw, Dow swung 600 pts intraday, closed flat. SKORE: PVH 7.8 Buy · NCNO 7.4 Buy · CAG 5.2 Hold.
The Goldilocks macro environment that opened 2026 ended on 28 February. US-Israel strikes on Iran triggered the largest oil supply disruption on record. Growth forecasts cut. Inflation forecasts raised. The stagflation risk is back — with less ammunition to fight it.
U.S. equity futures were slightly lower to flat ahead of the open. Nasdaq futures showed mild weakness after the sharp rally earlier in the week. S&P 500 and Dow futures were near unchanged to slightly negative.
Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.050-0.070 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared
